rubella vaccine vaccine used prevent effectiveness begins two weeks single dose around people become immune countries high rates immunization longer see cases rubella congenital rubella syndrome low level childhood immunization population possible rates congenital rubella increase women make childbearing age without either vaccination exposure disease therefore important people introducing rubella containing vaccines rubella eradicated nations world health organization recommends rubella vaccine included routine vaccinations people immunized least women childbearing age immunized given pregnant poor immune function one dose often required lifelong protection often two doses side effects generally mild may include fever rash pain redness site injection joint pain may reported one three weeks following vaccination women severe allergies rare rubella vaccine live attenuated vaccine available either combination vaccines combinations include measles mr vaccine measles mumps vaccine mmr vaccine measles mumps varicella vaccine mmrv rubella vaccine first licensed world health organizations list essential countries included routine rubella vaccine world health organizations list essential two main ways deliver rubella vaccine first initially efforts immunize people less forty years old followed providing first dose vaccine months age otherwise simply women childbearing age one dose necessary two doses often given usually comes mixed measles women planning become pregnant recommended rubella immunity beforehand virus potential cause miscarriage serious birth immunity may verified prepregnancy blood test recommended negative results refrain getting pregnant least month receiving vaccine theoretically given pregnancy however thousand women given vaccine realize pregnant negative outcomes occurred testing pregnancy giving vaccine low titre found pregnancy vaccine given delivery also advisable avoid becoming pregnant four weeks following administration since rubella epidemics swept europe us several efforts made develop effective vaccines using attenuated viral strains us first successful strain used prepared passing virus cells african green monkey kidney times efforts develop vaccine conducted team researchers national institutes healths division biologics standards lead harry meyer paul j parkman team included hope e ruth l kirschstein rudyard wallace among others team began serious work vaccine arrival major rubella epidemic united states prior arriving national institutes health nih parkman working isolating rubella virus army joined laboratory harry parkman meyer team nih tested vaccine childrens colony conway arkansas rubella epidemic still raged across united residential home provided care children cognitive disabilities children ill ability isolate children cabins control access children made ideal location testing vaccine without starting epidemic rubella childrens parents provided consent participation june nih issued first license commercial production rubella vaccine pharmaceutical company merck sharp vaccine made use rubella strain produced duck embryo cells version rubella vaccine use years introduction combined measles mumps rubella mmr vaccine modern rubella vaccines including combination vaccine mmr contain ra developed stanley plotkin leonard hayflick wistar institute philadelphia vaccine attenuated prepared normal human diploid cell strain developed gifted plotkin order isolate virus instead taking swab samples throats infected patients could contaminated resident viruses plotkin decided utilize aborted fetuses provided department obstetrics gynecology hospital university pennsylvania time abortion illegal united states including pennsylvania doctors allowed perform therapeutic abortions life woman danger started perform also women infected several dozens aborted fetuses collected studied plotkin kidney tissue fetus produced strain used develop attenuated rubella vaccine name ra refers rubella abortus fetus organ harvested vaccine first approved uk strain became preferred vaccine used pharmaceutical companies due several considerations including higher immunogenicity merck made mainstay rubella vaccine rubella seldom given individual vaccine often given combination measles mumps varicella chickenpox list measlescontaining vaccines httpsenwikipediaorgwikirubellavaccine